Vimentin regulates activation of the NLRP3 inflammasome

Citations Over TimeTop 10% of 2015 papers

Abstract

Activation of the NLRP3 inflammasome and subsequent maturation of IL-1β have been implicated in acute lung injury (ALI), resulting in inflammation and fibrosis. We investigated the role of vimentin, a type III intermediate filament, in this process using three well-characterized murine models of ALI known to require NLRP3 inflammasome activation. We demonstrate that central pathophysiologic events in ALI (inflammation, IL-1β levels, endothelial and alveolar epithelial barrier permeability, remodelling and fibrosis) are attenuated in the lungs of Vim(-/-) mice challenged with LPS, bleomycin and asbestos. Bone marrow chimeric mice lacking vimentin have reduced IL-1β levels and attenuated lung injury and fibrosis following bleomycin exposure. Furthermore, decreased active caspase-1 and IL-1β levels are observed in vitro in Vim(-/-) and vimentin-knockdown macrophages. Importantly, we show direct protein-protein interaction between NLRP3 and vimentin. This study provides insights into lung inflammation and fibrosis and suggests that vimentin may be a key regulator of the NLRP3 inflammasome.

Related Papers

• → Proapoptotic Bid is required for pulmonary fibrosis(2006)118 cited
• → Biphasic effects of free radical scavengers against bleomycin-induced pulmonary fibrosis(2008)12 cited
• Effect of peimisine on pulmonary interstitial fibrosis induced by bleomycin in mouse pulmonary fibrosis.(2024)
• Research on intervention effect of breviscapme injection on rats with pulmonary fibrosis(2009)
• Effects of epigallocatechin gallate on rats with pulmonary fibrosis induced by bleomycin(2009)